topic

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
Shiro Takamatsu, Junzo Hamanishi, J B Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004831; DOI: 10.1136/jitc-2022-004831
PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy
Ruhul H Choudhury, Peter Symonds, Samantha J Paston, Ian Daniels, Katherine W Cook, Mohamed Gijon, Rachael L Metheringham, Victoria A Brentville, Lindy G Durrant

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003526; DOI: 10.1136/jitc-2021-003526
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial
Scott S Tykodi, Lucio N Gordan, Robert S Alter, Edward Arrowsmith, Michael R Harrison, Ivor Percent, Rakesh Singal, Peter Van Veldhuizen, Daniel J George, Thomas Hutson, Joshua Zhang, Jesus Zoco, Jennifer L Johansen, Arash Rezazadeh Kalebasty

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003844; DOI: 10.1136/jitc-2021-003844
Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer
Yumeng Wang, Congwen Wang, Junjun Qiu, Xinyu Qu, Jing Peng, Chong Lu, Meng Zhang, Mingxing Zhang, Xingling Qi, Guiling Li, Keqin Hua

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003667; DOI: 10.1136/jitc-2021-003667
Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation
Lei Wen, Zhigang Chen, Xiaomeng Ji, William Pat Fong, Qiong Shao, Chao Ren, Yanyu Cai, Binkui Li, Yunfei Yuan, Deshen Wang, Yuhong Li

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e004487; DOI: 10.1136/jitc-2022-004487
Correction: Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003554corr1; DOI: 10.1136/jitc-2021-003554corr1
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer
Katy McCann, Adrian von Witzleben, Jaya Thomas, Chuan Wang, Oliver Wood, Divya Singh, Konstantinos Boukas, Kaidre Bendjama, Nathalie Silvestre, Finn Cilius Nielsen, Gareth Thomas, Tilman Sanchez-Elsner, Jason Greenbaum, Stephen Schoenberger, Bjoern Peters, Pandurangan Vijayanand, Natalia Savelyeva, Christian Ottensmeier

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003821; DOI: 10.1136/jitc-2021-003821
Tumor cell SYK expression modulates the tumor immune microenvironment composition in human cancer via TNF-α dependent signaling
Adam Aguirre-Ducler, Nicole Gianino, Franz Villarroel-Espindola, Shruti Desai, Daiwei Tang, Hongyu Zhao, Konstantinos Syrigos, William L Trepicchio, Karuppiah Kannan, Richard C Gregory, Kurt A Schalper

Journal for ImmunoTherapy of Cancer Jul 2022, 10 (7) e005113; DOI: 10.1136/jitc-2022-005113
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience
M Lia Palomba, David Qualls, Sebastien Monette, Shenon Sethi, Ahmet Dogan, Mikhail Roshal, Brigitte Senechal, Xiuyan Wang, Isabelle Rivière, Michel Sadelain, Renier J Brentjens, Jae H Park, Eric L Smith

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e004128; DOI: 10.1136/jitc-2021-004128
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
Taketo Kawai, Satoru Taguchi, Tohru Nakagawa, Jun Kamei, Yu Nakamura, Daisuke Obinata, Kenya Yamaguchi, Tomoyuki Kaneko, Shigenori Kakutani, Mayuko Tokunaga, Yukari Uemura, Yusuke Sato, Yutaka Enomoto, Hiroaki Nishimatsu, Tetsuya Fujimura, Hiroshi Fukuhara, Satoru Takahashi, Haruki Kume

Journal for ImmunoTherapy of Cancer Feb 2022, 10 (2) e003965; DOI: 10.1136/jitc-2021-003965

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages